Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
202.77
-2.38 (-1.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corp
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Insulet Corporation (PODD) Q3 2021 Earnings Call Transcript
November 04, 2021
PODD earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Insulet Posts Mixed Third Quarter, But Raises Sales Guide On Narrow Beat
November 04, 2021
Insulet raised its full-year sales outlook Thursday on its third-quarter sales beat.
Via
Investor's Business Daily
Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year
November 04, 2021
From
Insulet Corporation
Via
Business Wire
Insulet Honors Diabetes Awareness with Global Activities and Events
November 01, 2021
From
Insulet Corporation
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford
October 18, 2021
From
Insulet Corporation
Via
Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Insulet's Insulin Delivery System Shows Durable Glycemic Control With One Year of Use
September 30, 2021
Insulet Corporation (NASDAQ: PODD) presented data from the pivotal trial extension phase of the Omnipod 5 Automated Insulin Delivery System. Omnipod 5 is a...
Via
Benzinga
Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use
September 30, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021
September 29, 2021
From
Insulet Corporation
Via
Business Wire
5 Top Stocks for September
September 11, 2021
Our analysts give you five picks you can add to your portfolio today.
Via
The Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Insulet to Present at Upcoming Investor Conferences
August 26, 2021
From
Insulet Corporation
Via
Business Wire
Looking into Insulet's Return on Capital Employed
August 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Insulet (NASDAQ:PODD) earned $26.30 million, a 61.35% increase from the preceding quarter. Insulet also posted a...
Via
Benzinga
FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps
August 16, 2021
The
Via
Benzinga
Exposures
Product Safety
Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
August 16, 2021
From
Insulet Corporation
Via
Business Wire
Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress
August 11, 2021
From
Insulet Corporation
Via
Business Wire
Insulet Stock Dives On Unexpected Delay For Next-Generation Insulin Pump
August 06, 2021
Insulet said Thursday it expects a one-quarter delay for its next-generation insulin pump, leading PODD stock to tumble on Friday.
Via
Investor's Business Daily
Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript
August 06, 2021
PODD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year
August 05, 2021
From
Insulet Corporation
Via
Business Wire
3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain
July 31, 2021
Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.
Via
The Motley Fool
Exposures
COVID-19
Insulet to Present at Upcoming Investor Conferences
July 26, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021
July 01, 2021
From
Insulet Corporation
Via
Business Wire
Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
June 26, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System
June 24, 2021
From
Insulet Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Insulet Corp (PODD) Q1 2021 Earnings Call Transcript
May 07, 2021
PODD earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
May 06, 2021
From
Insulet Corporation
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.